Mining Toronto

Three months after launching the Blueline Bioscience incubator to scour the Toronto area for early stage projects, Versant Ventures has lined up a ready-made exit strategy by giving Celgene Corp. (NASDAQ:CELG) opt-in rights on incubated startups in fields of joint interest.